VivoSim Labs, Inc. Debt Instrument, Convertible, Number of Equity Instruments
VivoSim Labs, Inc. (VIVS) reported Debt Instrument, Convertible, Number of Equity Instruments of 1.53 million Investment for the 1-month period ending 2012-02-29, per its 10-K filed 2014-06-10.
Discontinued › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentConvertibleNumberOfEquityInstruments · last filed 2014-06-10
- 2012-02-29: Debt Instrument, Convertible, Number of Equity Instruments 1 month 1.53M Investment.
| Period end | Debt Instrument, Convertible, Number of Equity Instruments 1 month |
|---|---|
| 2012-02-29 | 1.53M Investment 10-K · filed 2014-06-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |